" class="no-js "lang="en-US"> Anona Bamford, PerkinElmer, on Single-Cell RNA Sequencing
Thursday, June 08, 2023

Breaking News

Mendus and NorthX Biologics to Enter into Strategic Cell Therapy Manufacturing Alliance Supported by New Investor Flerie SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Abivax Appoints Ida Hatoum as Chief People Officer

May 9 2023

Anona Bamford Ph.D., PerkinElmer Applied Genomics, on Single-Cell RNA Sequencing

In this interview with Anona Bamford from PerkinElmer at the 33rd ECCMID 2023 event, she discusses a range of products and PerkinElmer acquisitions that are helping scientists and healthcare professionals achieve a healthier world.

Bamford highlights the role of new technologies, such as next-generation RNA sequencing. She explains how these technologies can provide more precise and comprehensive information, which can help with the development of targeted treatments, as well as helping keep costs down.

Anona Bamford finishes the interview by sharing new products that are expected to be launched by the end of the year.

Companies In This Post

PerkinElmer | Pharmtech Focus

PerkinElmer
  1. Mendus and NorthX Biologics to Enter into Strategic Cell Therapy Manufacturing Alliance Supported by New Investor Flerie

    News

     Read more
  2. SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment

    Clinical Trials

     Read more
  3. Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO

    Appointments

     Read more
  4. Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases

    Diseases

     Read more
  5. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes

    News

     Read more
More On